Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66

Introduction: Na+-K+-2Cl− cotransporter isoform 1 (NKCC1) is important in regulating intracellular K+ and Cl− homeostasis and cell volume. In this study, we investigated a role of NKCC1 in regulating glioma K+ influx and proliferation in response to apoptosis inducing chemotherapeutic drug temozolom...

Full description

Bibliographic Details
Main Authors: Lanxin Luo, Jun Wang, Dawei Ding, Md Nabiul Hasan, Sung-Sen Yang, Shih-Hua Lin, Philipp Schreppel, Baoshan Sun, Yan Yin, Thomas Erker, Dandan Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.00911/full
_version_ 1818290340304519168
author Lanxin Luo
Lanxin Luo
Jun Wang
Jun Wang
Dawei Ding
Dawei Ding
Md Nabiul Hasan
Sung-Sen Yang
Shih-Hua Lin
Philipp Schreppel
Baoshan Sun
Yan Yin
Thomas Erker
Dandan Sun
Dandan Sun
author_facet Lanxin Luo
Lanxin Luo
Jun Wang
Jun Wang
Dawei Ding
Dawei Ding
Md Nabiul Hasan
Sung-Sen Yang
Shih-Hua Lin
Philipp Schreppel
Baoshan Sun
Yan Yin
Thomas Erker
Dandan Sun
Dandan Sun
author_sort Lanxin Luo
collection DOAJ
description Introduction: Na+-K+-2Cl− cotransporter isoform 1 (NKCC1) is important in regulating intracellular K+ and Cl− homeostasis and cell volume. In this study, we investigated a role of NKCC1 in regulating glioma K+ influx and proliferation in response to apoptosis inducing chemotherapeutic drug temozolomide (TMZ). The efficacy of a new bumetanide (BMT)-derivative NKCC1 inhibitor STS66 [3-(butylamino)-2-phenoxy-5-[(2, 2, 2-trifluoroethylamino) methyl] benzenesulfonamide] in blocking NKCC1 activity was compared with well-established NKCC1 inhibitor BMT.Methods: NKCC1 activity in cultured mouse GL26 and SB28-GFP glioma cells was measured by Rb+ (K+) influx. The WNK1-SPAK/OSR1-NKCC1 signaling and AKT/ERK-mTOR signaling protein expression and activation were assessed by immunoblotting. Cell growth was determined by bromodeoxyuridine (BrdU) incorporation assay, MTT proliferation assay, and cell cycle analysis. Impact of STS66 and BMT on cell Rb+ influx and growth was measured in glioma cells treated with or without TMZ.Results: Rb+ influx assay showed that 10 μM BMT markedly decreased the total Rb+ influx and no additional inhibition detected at >10 μM BMT. In contrast, the maximum effects of STS66 on Rb+ influx inhibition were at 40–60 μM. Both BMT and STS66 reduced TMZ-mediated NKCC1 activation and protein upregulation. Glioma cell growth can be reduced by STS66. The most robust inhibition of glioma growth, cell cycle, and AKT/ERK signaling was achieved by the TMZ + STS66 treatment.Conclusion: The new BMT-derivative NKCC1 inhibitor STS66 is more effective than BMT in reducing glioma cell growth in part by inhibiting NKCC1-mediated K+ influx. TMZ + STS66 combination treatment reduces glioma cell growth via inhibiting cell cycle and AKT-ERK signaling.
first_indexed 2024-12-13T02:26:37Z
format Article
id doaj.art-12fe751a292449c5b17969be452db028
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-13T02:26:37Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-12fe751a292449c5b17969be452db0282022-12-22T00:02:37ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2020-07-011110.3389/fphys.2020.00911561138Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66Lanxin Luo0Lanxin Luo1Jun Wang2Jun Wang3Dawei Ding4Dawei Ding5Md Nabiul Hasan6Sung-Sen Yang7Shih-Hua Lin8Philipp Schreppel9Baoshan Sun10Yan Yin11Thomas Erker12Dandan Sun13Dandan Sun14Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, United StatesDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Neurology, The Second Hospital of Dalian Medical University, Dalian, ChinaDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, United StatesDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanDepartment of Medicinal Chemistry, University of Vienna, Vienna, AustriaPólo Dois Portos, Instituto National de Investigação Agrária e Veterinária, I.P., Quinta da Almoinha, Dois Portos, PortugalDepartment of Neurology, The Second Hospital of Dalian Medical University, Dalian, ChinaDepartment of Medicinal Chemistry, University of Vienna, Vienna, AustriaDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United StatesVeterans Affairs Pittsburgh Health Care System, Geriatric Research, Educational and Clinical Center, Pittsburgh, PA, United StatesIntroduction: Na+-K+-2Cl− cotransporter isoform 1 (NKCC1) is important in regulating intracellular K+ and Cl− homeostasis and cell volume. In this study, we investigated a role of NKCC1 in regulating glioma K+ influx and proliferation in response to apoptosis inducing chemotherapeutic drug temozolomide (TMZ). The efficacy of a new bumetanide (BMT)-derivative NKCC1 inhibitor STS66 [3-(butylamino)-2-phenoxy-5-[(2, 2, 2-trifluoroethylamino) methyl] benzenesulfonamide] in blocking NKCC1 activity was compared with well-established NKCC1 inhibitor BMT.Methods: NKCC1 activity in cultured mouse GL26 and SB28-GFP glioma cells was measured by Rb+ (K+) influx. The WNK1-SPAK/OSR1-NKCC1 signaling and AKT/ERK-mTOR signaling protein expression and activation were assessed by immunoblotting. Cell growth was determined by bromodeoxyuridine (BrdU) incorporation assay, MTT proliferation assay, and cell cycle analysis. Impact of STS66 and BMT on cell Rb+ influx and growth was measured in glioma cells treated with or without TMZ.Results: Rb+ influx assay showed that 10 μM BMT markedly decreased the total Rb+ influx and no additional inhibition detected at >10 μM BMT. In contrast, the maximum effects of STS66 on Rb+ influx inhibition were at 40–60 μM. Both BMT and STS66 reduced TMZ-mediated NKCC1 activation and protein upregulation. Glioma cell growth can be reduced by STS66. The most robust inhibition of glioma growth, cell cycle, and AKT/ERK signaling was achieved by the TMZ + STS66 treatment.Conclusion: The new BMT-derivative NKCC1 inhibitor STS66 is more effective than BMT in reducing glioma cell growth in part by inhibiting NKCC1-mediated K+ influx. TMZ + STS66 combination treatment reduces glioma cell growth via inhibiting cell cycle and AKT-ERK signaling.https://www.frontiersin.org/article/10.3389/fphys.2020.00911/fullbumetanidebumetanide-derivative STS66cell volume regulationgliomaK+ influxNa+-K+-Cl− cotransporter
spellingShingle Lanxin Luo
Lanxin Luo
Jun Wang
Jun Wang
Dawei Ding
Dawei Ding
Md Nabiul Hasan
Sung-Sen Yang
Shih-Hua Lin
Philipp Schreppel
Baoshan Sun
Yan Yin
Thomas Erker
Dandan Sun
Dandan Sun
Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
Frontiers in Physiology
bumetanide
bumetanide-derivative STS66
cell volume regulation
glioma
K+ influx
Na+-K+-Cl− cotransporter
title Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
title_full Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
title_fullStr Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
title_full_unstemmed Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
title_short Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66
title_sort role of nkcc1 activity in glioma k homeostasis and cell growth new insights with the bumetanide derivative sts66
topic bumetanide
bumetanide-derivative STS66
cell volume regulation
glioma
K+ influx
Na+-K+-Cl− cotransporter
url https://www.frontiersin.org/article/10.3389/fphys.2020.00911/full
work_keys_str_mv AT lanxinluo roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT lanxinluo roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT junwang roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT junwang roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT daweiding roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT daweiding roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT mdnabiulhasan roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT sungsenyang roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT shihhualin roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT philippschreppel roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT baoshansun roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT yanyin roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT thomaserker roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT dandansun roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66
AT dandansun roleofnkcc1activityingliomakhomeostasisandcellgrowthnewinsightswiththebumetanidederivativests66